Updates from The Motley Fool

Latest updates on Cepheid from Fool.com.


Stock Performance

CPHD vs. S&P 500 | 2 Year Performance
CPHD 1-Day Stock Chart
CPHD 5-Day Stock Chart
CPHD 1-Month Stock Chart
CPHD 3-Month Stock Chart
CPHD 6-Month Stock Chart
CPHD 1-Year Stock Chart
CPHD 2-Year Stock Chart
CPHD 5-Year Stock Chart
View Interactive CPHD Charts
Sponsored by

Key Data Points

Primary metrics and data points about Cepheid.
Current Price: $25.97
Prev Close: $25.79
Open: $25.87
Bid: $25.71
Ask: $26.55
Day's Range: $25.65 - $26.32
52wk Range: $25.43 - $63.69
Volume: 674,829
Avg Vol 789,894
Market Cap: $1.88B
P/E (ttm): -33.49
EPS (ttm): -$0.76
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Cepheid.
CAPS Rating 3 out of 5
 
242 Outperform
25 Underperform
CAPS All Stars
 
40 Outperform
8 Underperform

How do you think Cepheid will perform against the market?



You pick for Cepheid is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John L. Bishop, CEO

75% Approve

Based on 29 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Cepheid.

A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.

  • Exchange: NASDAQ
  • Sector: Technology
  • Industry: Electronics